Security key
036752202
- Security type / class
- Equity / PREFERRED STOCK
- Total 13F shares
- 23,637,084
- Total 13F value
- $1,269,619,897
- Share change
- +500,255
- SEC-reported price per share
- $53.70
- Number of holders
- 56
- Value change
- +$22,057,134
- Number of buys
- 18
- Number of sells
- 41
Report period
Q1 2018
Institutions
56
Top holders
10
ANTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
AN2 Therapeutics, Inc. SEC filings
AN2 Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 036752202
Recent filing periods:
Ownership snapshot
Top reported holders of ANTX - ELEVANCE HEALTH INC - PREFERRED STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Dec 2017
13F
Highest disclosed value: $168,552,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $168.55M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock Finance, Inc.
$168.55M
AQR Arbitrage LLC
$108M
Allianz Asset Management GmbH
$98.5M
Calamos Advisors LLC
$89.07M
FMR LLC
$83.93M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$168,552,000
3,009,850 shares
|
— | 31 Dec 2017 |
| AQR Arbitrage LLC |
13F
Company
|
—
denominator unverified
|
$108,000,000
1,920,000 shares
|
— | 31 Dec 2017 |
| Allianz Asset Management GmbH |
13F
Company
|
—
denominator unverified
|
$98,495,000
1,758,835 shares
|
— | 31 Dec 2017 |
| Calamos Advisors LLC |
13F
Company
|
—
denominator unverified
|
$89,071,000
1,590,555 shares
|
— | 31 Dec 2017 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$83,928,000
1,498,708 shares
|
— | 31 Dec 2017 |
| Invesco Ltd. |
13F
Company
|
—
denominator unverified
|
$61,397,000
1,096,378 shares
|
— | 31 Dec 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
56
Shares
23,637,084
Rows available
56
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2018 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q1 2018 holders
56
Holder diff
55
| Investor | Q1 2026 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend